| Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance (NCT03880058) | Scarless Laboratories, Inc. | 2019-03-03 |
| NeoVax Plus Ipilimumab in Renal Cell Carcinoma (NCT02950766) | Patrick Ott, MD, PhD | 2019-03-03 |
| Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes (NCT04289948) | University Hospitals of Derby and Burton NHS Foundation Trust | 2019-03-01 |
| Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer (NCT04110093) | Shanghai Changzheng Hospital | 2019-03-01 |
| Evaluating Effect of Cognitive Game Based Treadmill Exercise Program in Parkinson Disease (NCT03835611) | University of Manitoba | 2019-03-01 |
| Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis (NCT03810521) | Universidad de los Andes, Chile | 2019-03-01 |
| Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas (NCT03373305) | City of Hope Medical Center | 2019-03-01 |
| An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer (NCT03989310) | Chinese PLA General Hospital | 2019-03-01 |
| An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder (NCT03861338) | New York State Psychiatric Institute | 2019-03-01 |
| Single Ascending Oral Doses of SY-009 in Healthy Subjects (NCT04119947) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2019-03-01 |
| Jianpi Huoxue Recipe in Treating Gastric Premalignant Lesion (NCT03823248) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2019-03-01 |
| Prone Positioning and Spontaneous Breathing (NCT03768154) | Osaka University | 2019-03-01 |
| TopSpin360 in Female Varsity Athletes (NCT03844087) | TopSpin Technologies Ltd | 2019-03-01 |
| Pharmacological Activation of HMN for OSA Aim 2 (NCT03858751) | Brigham and Women's Hospital | 2019-03-01 |
| EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC (NCT04139057) | Xinqiao Hospital of Chongqing | 2019-03-01 |
| A Study of Safety and Tolerability of NOX66 in Healthy Volunteers (NCT03780465) | Noxopharm Limited | 2019-03-01 |
| A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC (NCT04004234) | Chinese PLA General Hospital | 2019-03-01 |
| Careseng 1370 for Chemotherapy-Induced Myelosuppression (NCT03692780) | Careseng Biotech Co., Ltd. | 2019-03-01 |
| Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia (NCT02601365) | Milton S. Hershey Medical Center | 2019-03-01 |
| Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly (NCT06449040) | Hospital Universitário Professor Edgard Santos | 2019-03-01 |
| A Remotely Delivered Episodic Future Thinking Intervention to Improve Management of Type 2 Diabetes (NCT03732209) | Virginia Polytechnic Institute and State University | 2019-03-01 |
| Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma (NCT04162158) | Beijing 302 Hospital | 2019-03-01 |
| Effect of Gel Renewal During In-office Dental Bleaching (NCT04013659) | Universidade Ibirapuera | 2019-03-01 |
| Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency (NCT05737329) | Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare | 2019-03-01 |
| Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot) (NCT03860753) | The University of Texas Health Science Center, Houston | 2019-03-01 |
| Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer (NCT03888612) | Arvinas Inc. | 2019-03-01 |
| Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia (NCT05149339) | Zagazig University | 2019-03-01 |
| A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers (NCT03818295) | Cyclerion Therapeutics | 2019-03-01 |
| Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis (NCT03866330) | Medical University of Warsaw | 2019-03-01 |
| The Influence of ANS-6637 on Midazolam Pharmacokinetics in Healthy Volunteers (NCT03831971) | National Institutes of Health Clinical Center (CC) | 2019-03-01 |
| Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma (NCT03682276) | Imperial College London | 2019-03-01 |
| Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520 (NCT03657381) | Shandong New Time Pharmaceutical Co., LTD | 2019-03-01 |
| Delineation of Sensorimotor Subtypes Underlying Residual Speech Errors (NCT03736213) | New York University | 2019-03-01 |
| Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer (NCT03808701) | Sinocelltech Ltd. | 2019-03-01 |
| Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia (NCT03348033) | Hospital de Clinicas de Porto Alegre | 2019-03-01 |
| Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia (NCT04062136) | Vinmec Research Institute of Stem Cell and Gene Technology | 2019-03-01 |
| Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy (NCT03903185) | Ain Shams University | 2019-03-01 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer (NCT03775525) | Genzada Pharmaceuticals USA, Inc. | 2019-03-01 |
| A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers (NCT03783403) | Celgene | 2019-03-01 |
| Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia (NCT03774537) | Children's Hospital of Chongqing Medical University | 2019-03-01 |
| Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients (NCT03844555) | Genfit | 2019-02-28 |
| A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer (NCT03941873) | BeiGene | 2019-02-28 |
| Inflammatory Markers in Trauma Patient Outcomes (NCT03671746) | Arun Aneja | 2019-02-28 |
| A Single Dose-escalation Study of Cytisine in Adult Smokers (NCT03848208) | Achieve Life Sciences | 2019-02-28 |
| Drug-Drug Interaction Between PK101-001 and PK101-002 (NCT03553316) | PMG Pharm Co., Ltd | 2019-02-28 |
| A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participants (NCT03891108) | Bristol-Myers Squibb | 2019-02-28 |
| A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects (NCT03929172) | 2A Pharma AB | 2019-02-28 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B (NCT03787758) | Supernus Pharmaceuticals, Inc. | 2019-02-28 |
| Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers (NCT03824171) | Addpharma Inc. | 2019-02-28 |
| Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours (NCT04810208) | Lidds AB | 2019-02-28 |
| Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia (NCT03705858) | Joseph Jurcic | 2019-02-28 |
| Comparison of Bioavailability of Dexketoprofen-Vit B vs Dexketoprofen, in Healthy Subjects, Under Fasting Conditions (NCT05027126) | Laboratorios Silanes S.A. de C.V. | 2019-02-28 |
| Safety Evaluation and Effect of Food Supplement Containing Dietary Fiber From Cassava on the Alterations of Physiological Parameters in Overweight Female Volunteers (NCT04013490) | Khon Kaen University | 2019-02-27 |
| Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream (NCT03892564) | MC2 Therapeutics | 2019-02-27 |
| Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES (NCT03879382) | Hrain Biotechnology Co., Ltd. | 2019-02-27 |
| A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men (NCT03837964) | Boehringer Ingelheim | 2019-02-27 |
| Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT03862157) | M.D. Anderson Cancer Center | 2019-02-27 |
| A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants (NCT03849690) | Millennium Pharmaceuticals, Inc. | 2019-02-27 |
| A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies (NCT03913741) | Genmab | 2019-02-27 |
| Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies (NCT03881774) | Henan Cancer Hospital | 2019-02-27 |
| Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors (NCT04324372) | Sunshine Lake Pharma Co., Ltd. | 2019-02-27 |
| Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer (NCT03786081) | Seagen, a wholly owned subsidiary of Pfizer | 2019-02-27 |
| Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788 (NCT03849872) | Ono Pharmaceutical Co., Ltd. | 2019-02-27 |
| A Bridging Study of the SYN023 on Healthy Adult Subjects (NCT04495569) | Synermore Biologics (Suzhou) Co., Ltd. | 2019-02-26 |
| BATs in Patients With Breast Cancer and Leptomeningeal Metastases (NCT03661424) | University of Virginia | 2019-02-26 |
| A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects (NCT03830528) | Kyowa Kirin Co., Ltd. | 2019-02-26 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers (NCT03858725) | Chong Kun Dang Pharmaceutical | 2019-02-26 |
| A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2) (NCT03861793) | Mural Oncology, Inc | 2019-02-26 |
| Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult Participants (NCT03866434) | Shire | 2019-02-26 |
| Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") (NCT03400254) | Abramson Cancer Center at Penn Medicine | 2019-02-26 |
| An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage (NCT03890809) | Bristol-Myers Squibb | 2019-02-26 |
| Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors (NCT03792958) | AnewPharma | 2019-02-26 |
| Safety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1) (NCT03870945) | Miltenyi Biomedicine GmbH | 2019-02-25 |
| The Effect of Intravenous Ketamine on Non Suicidal Self Injuries. (NCT04242914) | Tel-Aviv Sourasky Medical Center | 2019-02-25 |
| Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults (NCT03849287) | Chong Kun Dang Pharmaceutical | 2019-02-25 |
| To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers (NCT03650075) | Metagone Biotech Inc. | 2019-02-25 |
| Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors (NCT04001075) | TJ Biopharma Co., Ltd. | 2019-02-25 |
| The PK/PD Study of SHR2285 Tablets in Healthy Subjects (NCT03769831) | Jiangsu HengRui Medicine Co., Ltd. | 2019-02-25 |
| Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma (NCT03711864) | Peking Union Medical College Hospital | 2019-02-25 |
| The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in Preterms (NCT03855202) | yangjie | 2019-02-24 |
| Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin (NCT04262765) | Midas Pharma GmbH | 2019-02-23 |
| A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers (NCT03843060) | AstraZeneca | 2019-02-22 |
| Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen Oral Suspension (NCT05428293) | Laboratorios Silanes S.A. de C.V. | 2019-02-22 |
| Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis (NCT03846466) | Kyowa Kirin Co., Ltd. | 2019-02-22 |
| Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014) (NCT03745989) | Merck Sharp & Dohme LLC | 2019-02-22 |
| Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers (NCT03868072) | Chong Kun Dang Pharmaceutical | 2019-02-22 |
| Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept (NCT03396861) | Tufts Medical Center | 2019-02-22 |
| A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. (NCT04523987) | National University Hospital, Singapore | 2019-02-22 |
| Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C (NCT03471143) | Washington University School of Medicine | 2019-02-22 |
| Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers (NCT03860207) | Y-mAbs Therapeutics | 2019-02-22 |
| Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine (NCT03430089) | Sanofi Pasteur, a Sanofi Company | 2019-02-22 |
| Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease (NCT03491215) | Novartis Pharmaceuticals | 2019-02-21 |
| Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single-Dose of PF-06651600 in Healthy Participants (NCT03821493) | Pfizer | 2019-02-21 |
| Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study. (NCT03784040) | National University Hospital, Singapore | 2019-02-21 |
| Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors (NCT03821935) | AbbVie | 2019-02-21 |
| VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies (NCT03885947) | Alla Keyzner | 2019-02-21 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing (NCT03776500) | Innovative Medicines for Tuberculosis | 2019-02-21 |
| Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants (NCT05641311) | Alexion Pharmaceuticals, Inc. | 2019-02-20 |
| Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children (NCT03826901) | LEO Pharma | 2019-02-20 |
| Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia (NCT03862040) | Shionogi | 2019-02-20 |